dobutamine has been researched along with cromakalim in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lavallée, M; Okajima, M; Parent, R; Thorin, E | 1 |
1 other study(ies) available for dobutamine and cromakalim
Article | Year |
---|---|
Pathophysiological plasma ET-1 levels antagonize beta-adrenergic dilation of coronary resistance vessels in conscious dogs.
Topics: Adenosine; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Consciousness; Coronary Circulation; Coronary Vessels; Cromakalim; Dobutamine; Dogs; Drug Interactions; Endothelin A Receptor Antagonists; Endothelin-1; Ganglionic Blockers; Nitric Oxide; Oxygen Consumption; Receptor, Endothelin A; Receptors, Adrenergic, beta; Vascular Resistance; Vasodilation; Vasodilator Agents | 2004 |